Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
Saved in:
| Main Author: | PLOS ONE Editors |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction Note: Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice
by: Dalia S. Morsi, et al.
Published: (2025-03-01) -
Alfa-Lipoic Acid Controls Tumor Growth and Modulates Hepatic Redox State in Ehrlich-Ascites-Carcinoma-Bearing Mice
by: M. AL Abdan
Published: (2012-01-01) -
Study of diazepam effects on Ehrlich ascites carcinoma and anxiety responses in male SHK mice
by: T. S. Kalinina, et al.
Published: (2022-05-01) -
Hesperidin exacerbates the therapeutic potency of cisplatin against hepatocytotoxicity of Ehrlich ascites carcinoma in mice
by: Nahed Saleh, et al.
Published: (2025-06-01) -
Modulation of Cytokines Production by Indomethacin Acute Dose during the Evolution of Ehrlich Ascites Tumor in Mice
by: Luciana Boffoni Gentile, et al.
Published: (2015-01-01)